对于心肌梗塞中介细胞干细胞治疗的近期进展
Yu-Chuan He1, Guo-Dong Yuan2, Nan Li3
1Graduate School, Hebei University of Chinese Medicine, Shijiazhuang, Hebei, China.
Clinical hemorheology and microcirculation
|April 5, 2024
概括
介质干细胞 (MSC) 疗法在治疗心肌梗塞方面表现有前途,提供了一种有效和安全的方法. 需要进一步的研究来标准化MSC移植协议,以便在临床上广泛使用.
科学领域:
- 心脏病学 心脏病学
- 再生医学是一种再生医学.
- 干细胞生物学 干细胞生物学
背景情况:
- 心肌梗塞 (MI) 是由于冠状动脉封闭导致的心脏肌肉缺血性亡,这是一个主要的健康威胁.
- 目前用于减少心肌氧需求的治疗方法的成功程度有限.
- 中介细胞干细胞 (MSCs) 显示出对心脏病发作治疗的潜力.
研究的目的:
- 审查介质干细胞植入用于心肌梗塞的有效性和安全性.
- 确定心脏修复的MSC移植协议中的挑战和标准化领域.
主要方法:
- 对心肌梗塞中介细胞干细胞治疗的累积临床证据的审查.
- 对有关MSC移植方案,剂量和施用途径的现有数据进行分析.
主要成果:
- 临床证据表明,介质干细胞植入治疗心肌梗塞既有效又安全.
- 关于标准化MSC移植协议,最佳剂量和施用途径存在变化和争议.
结论:
- 介质细胞干细胞疗法是对心肌梗塞的有前途的治疗方法.
- 标准化MSC移植协议对于将这种疗法纳入主流心脏治疗至关重要.
相关概念视频
01:19Mesenchymal Stem Cells
4.7K
Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their...
4.7K
01:21Stem Cell Therapy for Tissue Regeneration
4.0K
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.0K